Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.964 |
28 |
|
2003 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.962 |
26 |
|
2003 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.970 |
33 |
|
2004 |
2019 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
High-Grade Squamous Intraepithelial Lesions
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
150
|
8
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Viral Encephalitis
|
group |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
35
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.070 |
None |
1.000 |
7 |
|
2006 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.070 |
None |
1.000 |
7 |
|
2006 |
2018 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
21 |
|
2009 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.090 |
None |
1.000 |
9 |
|
2009 |
2019 |
Malignant neoplasm of urinary bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2113
|
316
|
0.060 |
None |
1.000 |
6 |
|
2009 |
2017 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.060 |
None |
1.000 |
6 |
|
2009 |
2017 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.050 |
None |
1.000 |
5 |
|
2009 |
2016 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2018 |
cervical cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1817
|
268
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2018 |
Malignant tumor of cervix
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1718
|
245
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2018 |
Ocular Toxoplasmosis
|
disease |
Infections; Eye Diseases
|
Disease or Syndrome
|
35
|
9
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
invasive cancer
|
phenotype |
Neoplasms
|
Neoplastic Process
|
146
|
15
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Toxoplasmosis
|
disease |
Infections
|
Disease or Syndrome
|
112
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Blindness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
393
|
34
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2015 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
879
|
168
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2011 |